Progress of antibody-based inhibitors of the HGF–cMET axis in cancer therapy
Crossref DOI link: https://doi.org/10.1038/emm.2017.17
Published Online: 2017-03-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Ki-Hyun
Kim, Hyori
Text and Data Mining valid from 2017-03-24
Version of Record valid from 2017-03-24
Article History
Received: 8 December 2016
Accepted: 22 December 2016
First Online: 24 March 2017
Competing interests
: The authors declare no conflict of interest.